Colin Matthews
English composer
Colin Matthews's AcademicInfluence.com Rankings
Download Badge
Communications
Why Is Colin Matthews Influential?
(Suggest an Edit or Addition)According to Wikipedia, Colin Matthews, OBE is an English composer of contemporary classical music. Noted for his large-scale orchestral compositions, Matthews is also a prolific arranger of other composer's music, including works by Berlioz, Britten, Dowland, Mahler, Purcell and Schubert. Other arrangements include orchestrations of all Debussy's 24 Préludes, both books of Debussy's Images, and two movements—Oiseaux tristes and La vallée des cloches—from Ravel's Miroirs. Having received a doctorate from University of Sussex on the works of Mahler, from 1964–1975 Matthews worked with his brother David Matthews and musicologist Deryck Cooke on completing a performance version of Mahler's Tenth Symphony.
Colin Matthews's Published Works
Published Works
- DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers (2006) (327)
- Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648). (2008) (262)
- Semisynthesis and in vitro anticancer activities of andrographolide analogues. (2007) (127)
- Antitumour benzothiazoles. Part 20: 3'-cyano and 3'-alkynyl-substituted 2-(4'-aminophenyl)benzothiazoles as new potent and selective analogues. (2003) (103)
- Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones ('quinols'). (2006) (100)
- Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosis (2008) (91)
- Elucidation of thioredoxin as a molecular target for antitumor quinols. (2005) (75)
- Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzothiazoles. (2006) (69)
- Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes. (2005) (62)
- Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions. (2007) (40)
- Synthesis of novel C2-aryl pyrrolobenzodiazepines (PBDs) as potential antitumour agents. (2002) (35)
- Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines (2008) (33)
- The characterisation of flavone-DNA isoform interactions as a basis for anticancer drug development. (2009) (24)
- Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445) (2000) (24)
- Synthesis and antitumour evaluation of novel 2-phenylbenzimidazoles (2008) (19)
- Antitumor quinols: role of glutathione in modulating quinol-induced apoptosis and identification of putative cellular protein targets. (2006) (17)
- N3-Substituted Temozolomide Analogs Overcome Methylguanine-DNA Methyltransferase and Mismatch Repair Precipitating Apoptotic and Autophagic Cancer Cell Death (2014) (16)
- Antitumor Benzothiazoles. Part 20. 3′-Cyano and 3′-Alkynyl-Substituted 2-(4′-Aminophenyl)benzothiazoles as New Potent and Selective Analogues. (2003) (13)
- Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions. (2010) (9)
- Novel reaction products from the hypervalent iodine oxidation of hydroxylated stilbenes and isoflavones. (2005) (8)
- Structural studies on bioactive compounds. 39. Biological consequences of the structural modification of DHFR-inhibitory 2,4-diamino-6-(4-substituted benzylamino-3-nitrophenyl)-6-ethylpyrimidines ('benzoprims'). (2004) (8)
- Antitumor imidazo[5,1-d]-1,2,3,5-tetrazines: compounds modified at the 3-position overcome resistance in human glioblastoma cell lines (2016) (6)
- Synthesis and antitumour evaluation of novel 2-phenylbenzimidazoles. (2008) (4)
- Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design. (2001) (1)
- Synthesis of heteroaromatic quinols, novel agents with selective activity clustered in colon and renal cell lines (2002) (1)
- Induction of G1 arrest and apoptosis by new benzylidene derivatives of andrographolide in breast and colon cancer cells (2007) (1)
- Synthesis of Novel C2-Aryl Pyrrolobenzodiazepines (PBDs) as Potential Antitumor Agents. (2002) (0)
- Novel lead antitumour structures from oxygenated and hydroxylated bicyclic heterocycles (2002) (0)
- Thiol-interactive antitumor quinols as modulators of cellular redox homeostasis (2005) (0)
- 431 POSTER Elucidation of additional targets of the thioredoxin inhibitor PMX 464 (2006) (0)
- Abstract B164: Role of endoplasmic reticulum stress in mechanism of action of antitumor quinols (2009) (0)
- Patient specific therapies using aptamers: Selection of high affinity and specificity oligonucleotide ligands against human tumour cell lines (2003) (0)
- 306 POSTER Aryl hydrocarbon receptor ligands 2-(3,4-dimethoxyphenyl)-fluorobenzothiazoles elicit potent and selective in vitro antitumor activity, inducing DNA damage that is independent of CYP1A1 bioactivation (2006) (0)
- Thioredoxin-targeted experimental antitumor Quinols exert cytotoxicty following activation of apoptosis signal regulating kinase 1. (2007) (0)
- Subject Index Vol. 27, 2006 (2006) (0)
- 309 POSTER A systems biology approach to the analysis of DNA-interactive antitumour agents (2006) (0)
- Contents Vol. 27, 2006 (2006) (0)
This paper list is powered by the following services:
Other Resources About Colin Matthews
What Schools Are Affiliated With Colin Matthews?
Colin Matthews is affiliated with the following schools:
